Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Guardant Health

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Guardant Health stock took a tumble Thursday after the company's second-generation colon cancer test lagged expectations in a pivotal study.

Investors Business Daily

Stocks Showing Market Leadership: Guardant Health Earns 92 RS Rating

Guardant Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Stocks To Watch: Guardant Health Sees Relative Strength Rating Jump To 85

Guardant Health sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Medical Services Name Flirts With A Buy Point

This medical services stock is in a cup-with-handle base. The biotech's tests detect cancer through blood tests.

Investors Business Daily

Dow Jones Futures Rise As Trump Buys Time For Iran; Tesla Robotaxi To Have Safety Monitor

President Trump gave himself "two weeks" for an Iran decision. Tesla sent out robotaxi invites, with some key details..

Investors Business Daily

Guardant Health Joins Rank Of Stocks With RS Ratings Over 90

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

MarketBeat

Simple blood tests could be the future of cancer diagnosis

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

LiveScience

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test.

Investors Business Daily

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

Exact Sciences stock crumbled Thursday on its growing rivalry with Guardant Health and Natera in colon cancer screening.

Investors Business Daily

Guardant Health Shows Market Leadership With Jump To 92 RS Rating

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

Guardant Health Stock Sees RS Rating Jump To 83

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

Deciphering Disruption: Inside Cathie Wood's Latest Plays

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stocks Showing Improving Market Leadership: Guardant Health Earns 82 RS Rating

A Relative Strength Rating upgrade for Guardant Health shows improving technical performance.

Investors Business Daily

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop

Guardant Health stock jumped Thursday on an "impressive" third-quarter report following the launch of its cancer detection test, Shield.

Investors Business Daily

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat

Exact Sciences stock bounded higher Thursday after beating second-quarter expectations, signaling a return to growth for Cologuard.

Investors Business Daily

Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales

Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.

WEKU

A simple blood test can detect colorectal cancer early, study finds

At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection.

Top News

New Blood Test Shows Promise For Colon Cancer Screening

Learn about promising advancements in colon cancer screening methods, including new blood tests and improved stool tests, offering hope for increased early...

Barchart

A Hidden AI Stock to Add to Your Portfolio

Many AI techniques are already being used in healthcare, where the highest degree of accuracy is required. One such area is oncology testing and the cancer research programs of Guardant Health.

Investors Business Daily

Guardant Health Stock Sees Renewed Technical Strength

Guardant Health sees its Relative Strength Rating enter the 80-plus level.

Investors Business Daily

Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark

Guardant Health shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82.

Investors Business Daily

Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard

Guardant unveiled results for its colon cancer-detecting blood test that lagged rival Exact. GH stock crashed as EXAS stock jumped Friday.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.